3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Lung Transplant: new trials by email Literature Review of Lung Transplant trials Research Report on Lung Transplant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letermovir for CMV Prevention After Lung Transplantation Letermovir, Valganciclovir - Lung Transplant, CMV | Phase 2 | Completed | Fernanda P Silveira, MD, MS | 15 | 2021-12-06 | 2026-04-09 |
| Envarsus XR in Lung Transplant Extended-Release Tacrolimus, Immediate-Release Tacrolimus - Lung Transplant | Phase 2 | Completed | NYU Langone Health | 41 | 2020-10-23 | 2024-01-22 |
| B Cell Induction in Pediatric Lung Transplantation Rituximab (Rituxan®), Placebo - Lung Transplant | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2015-01-22 | 2021-10-26 |
Rituximab (1) · Tacrolimus (1) · Valganciclovir (1) · letermovir (1)
Fernanda P Silveira, MD, MS (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)
Fernanda Silveira (1) · Lara Danziger-Isakov, M.D., M.P.H. (1) · Luis Angel, MD (1) · Stuart Sweet, M.D., Ph.D. (1)